Andreas Von Deimling
#140,118
Most Influential Person Now
Andreas Von Deimling's AcademicInfluence.com Rankings
Andreas Von Deimlingphilosophy Degrees
Philosophy
#7285
World Rank
#10477
Historical Rank
Logic
#4342
World Rank
#5624
Historical Rank

Download Badge
Philosophy
Andreas Von Deimling's Degrees
- Doctorate Medicine Heidelberg University
- PhD Neuropathology Heidelberg University
Why Is Andreas Von Deimling Influential?
(Suggest an Edit or Addition)Andreas Von Deimling's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary (2016) (11090)
- Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma (2012) (2074)
- Oncogenic Signaling Pathways in The Cancer Genome Atlas (2018) (1646)
- DNA methylation-based classification of central nervous system tumours (2018) (1461)
- An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor (2011) (1423)
- Comprehensive Characterization of Cancer Driver Genes and Mutations (2018) (1360)
- Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas (2009) (1062)
- Analysis of the IDH1 codon 132 mutation in brain tumors (2008) (971)
- Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma (2011) (871)
- Dissecting the genomic complexity underlying medulloblastoma (2012) (777)
- Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations (2012) (755)
- Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas (2010) (714)
- Intracranial Thermotherapy using Magnetic Nanoparticles Combined with External Beam Radiotherapy: Results of a Feasibility Study on Patients with Glioblastoma Multiforme (2006) (662)
- Brain tumour cells interconnect to a functional and resistant network (2015) (655)
- Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma (2013) (637)
- New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs (2016) (608)
- A vaccine targeting mutant IDH1 induces antitumour immunity (2014) (576)
- Actively personalized vaccination trial for newly diagnosed glioblastoma (2018) (518)
- Epigenomic alterations define lethal CIMP-positive ependymomas of infancy (2014) (507)
- Pathogenic Germline Variants in 10,389 Adult Cancers (2018) (501)
- Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma (2014) (496)
- cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV” (2018) (492)
- Glioblastoma: pathology, molecular mechanisms and markers (2015) (482)
- Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody (2011) (456)
- DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3–26.1 is deleted in malignant brain tumours (1997) (452)
- The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma (2006) (449)
- Instability of short tandem repeats (microsatellites) in human cancers (1994) (440)
- MGMT testing—the challenges for biomarker-based glioma treatment (2014) (413)
- Monoclonal antibody specific for IDH1 R132H mutation (2009) (393)
- ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma (2014) (367)
- PTEN mutations in gliomas and glioneuronal tumors (1998) (366)
- Subsets of Glioblastoma Multiforme Defined by Molecular Genetic Analysis (1993) (348)
- ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis (2013) (298)
- Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein (2013) (292)
- Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers (2015) (269)
- Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma (2009) (261)
- Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system (2013) (254)
- cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas (2020) (253)
- Molecular Genetic Evidence for Subtypes of Oligoastrocytomas (1997) (252)
- Comparative Study of p53 Gene and Protein Alterations in Human Astrocytic Tumors (1993) (249)
- Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups (2015) (245)
- IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma (2015) (243)
- Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma (2014) (243)
- IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO (2015) (241)
- Novel, improved grading system(s) for IDH-mutant astrocytic gliomas (2018) (236)
- Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities (2015) (230)
- Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases (2012) (213)
- Oncogenic FAM131B–BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma (2011) (211)
- Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations (2013) (194)
- Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets (2016) (188)
- Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma (2014) (180)
- Report of the committee on chromosome and gene loss in human neoplasia (1991) (174)
- IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression (2020) (170)
- Brain metastases: pathobiology and emerging targeted therapies (2012) (168)
- A role for β-melanocyte-stimulating hormone in human body-weight regulation (2006) (168)
- Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells (2013) (158)
- Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma (2018) (154)
- Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations (2018) (154)
- Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity (2015) (145)
- CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas (2012) (144)
- Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo (2017) (135)
- Downregulation of RUNX3 and TES by hypermethylation in glioblastoma (2007) (129)
- Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettes (2010) (128)
- Methylation-based classification of benign and malignant peripheral nerve sheath tumors (2016) (126)
- INI1 mutations in meningiomas at a potential hotspot in exon 9 (2001) (123)
- Decreased hemispheric Aquaporin-4 is linked to evolving brain edema following controlled cortical impact injury in rats (2002) (123)
- Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology (2011) (123)
- IDH1/2 mutations in WHO grade II astrocytomas associated with localization and seizure as the initial symptom (2012) (122)
- H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers (2017) (121)
- Loss of NF1 Alleles Distinguish Sporadic from NF1‐Associated Pilocytic Astrocytomas (2001) (120)
- Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas (2015) (119)
- Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative `tumor progression' locus (1997) (114)
- Announcing cIMPACT-NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy (2016) (109)
- Molecular pathogenesis of oligodendroglial tumors (2004) (108)
- Novel genomic amplification targeting the microRNA cluster at 19q13.42 in a pediatric embryonal tumor with abundant neuropil and true rosettes (2008) (107)
- Molecular Genetics of Pediatric Brain Stem Gliomas. Application of PCR Techniques to Small and Archival Brain Tumor Specimens (1993) (106)
- Malignant peripheral nerve sheath tumours in neurofibromatosis type 1: MRI supports the diagnosis of malignant plexiform neurofibroma (2003) (105)
- Nuclear relocation of STAT6 reliably predicts NAB2–STAT6 fusion for the diagnosis of solitary fibrous tumour (2014) (101)
- BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinoma (2014) (100)
- A highly conserved processed PTEN pseudogene is located on chromosome band 9p21 (1998) (99)
- Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy (2014) (95)
- Neurofibromatosis Type 1: Pathology, Clinical Features and Molecular Genetics (1995) (94)
- Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours (2006) (93)
- PIK3CA mutations in glioblastoma multiforme (2005) (92)
- Low Frequency of SV40, JC and BK Polyomavirus Sequences in Human Medulloblastomas, Meningiomas and Ependymomas (2000) (91)
- Stem-cell-like glioma cells are resistant to TRAIL/Apo2L and exhibit down-regulation of caspase-8 by promoter methylation (2009) (91)
- Diagnostic, prognostic and predictive relevance of molecular markers in gliomas (2015) (87)
- Expression of αB‐crystallin in human brain tumors (1993) (85)
- 2‐Hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size (2012) (85)
- AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry (2013) (83)
- Histopathology and clinical outcome of NF1-associated vs. sporadic malignant peripheral nerve sheath tumors (2007) (81)
- Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant glioma (2013) (80)
- Microsatellite analysis of loss of heterozygosity on chromosomes 9q, 11 p and 17p in medulloblastomas (1994) (79)
- A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat (2011) (78)
- Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial (2012) (78)
- R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1α upregulation in adult glioma (2011) (75)
- Patterns of differentiation in central neurocytoma (1990) (73)
- A rapid and non‐radioactive PCR based assay for the detection of allelic loss in human gliomas (1993) (71)
- Biological and clinical heterogeneity of MYCN-amplified medulloblastoma (2012) (70)
- Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas (1999) (70)
- Chromosomal Imbalances in Brain Metastases of Solid Tumors (2000) (67)
- Gliomatosis cerebri: no evidence for a separate brain tumor entity (2016) (67)
- Hereditary Tumor Syndromes of the Nervous System: Overview and Rare Syndromes (1995) (65)
- Estimating cancer survival and clinical outcome based on genetic tumor progression scores (2005) (64)
- Deletions on the long arm of chromosome 17 in pilocytic astrocytoma (1993) (64)
- Interlaboratory comparison of IDH mutation detection (2013) (63)
- Melanotic Tumors of the Nervous System are Characterized by Distinct Mutational, Chromosomal and Epigenomic Profiles (2015) (62)
- BRAF‐Mutated Pleomorphic Xanthoastrocytoma is Associated with Temporal Location, Reticulin Fiber Deposition and CD34 Expression (2014) (62)
- No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomas (2012) (61)
- Isocitrate dehydrogenase 1 mutant R132H sensitizes glioma cells to BCNU-induced oxidative stress and cell death (2013) (61)
- Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gain (2015) (57)
- Enzymatic assay for quantitative analysis of (d)-2-hydroxyglutarate (2012) (56)
- Genetic Alterations Commonly Found in Diffusely Infiltrating Cerebral Gliomas Are Rare or Absent in Pleomorphic Xanthoastrocytomas (2002) (56)
- NF2 Mutations in Secretory and Other Rare Variants of Meningiomas (2006) (55)
- Pathology and molecular genetics of oligodendroglial tumors (2004) (53)
- Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors (2004) (53)
- BRAF V600E analysis for the differentiation of papillary craniopharyngiomas and Rathke's cleft cysts (2015) (53)
- A Rapid and Sensitive Protocol for Competitive Reverse Transcriptase (cRT) PCR Analysis of Cellular Genes (1998) (52)
- Improved molecular classification of serrated lesions of the colon by immunohistochemical detection of BRAF V600E (2014) (51)
- MMP-13, p53 in the Progression of Malignant Peripheral Nerve Sheath Tumors (2007) (50)
- Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q (2007) (50)
- Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes (2010) (50)
- Neuroradiology of central neurocytoma (2004) (47)
- Attitude towards clinical trials: Results of a survey of persons interested in research (2004) (46)
- Temozolomide chemotherapy versus radiotherapy in molecularly characterized (1p loss) low-grade glioma: A randomized phase III intergroup study by the EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033). (2013) (46)
- Involvement of Hif-1 in desferrioxamine-induced invasion of glioblastoma cells (2007) (45)
- Subclassification of Nerve Sheath Tumors by Gene Expression Profiling (2004) (45)
- FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma (2018) (43)
- A mutation-specific peptide vaccine targeting IDH1R132H in patients with newly diagnosed malignant astrocytomas: A first-in-man multicenter phase I clinical trial of the German Neurooncology Working Group (NOA-16). (2016) (42)
- BRAF V600E expression and distribution in desmoplastic infantile astrocytoma/ganglioglioma (2014) (40)
- Loss of FUBP1 expression in gliomas predicts FUBP1 mutation and is associated with oligodendroglial differentiation, IDH1 mutation and 1p/19q loss of heterozygosity (2014) (40)
- Neurofibromin specific antibody differentiates malignant peripheral nerve sheath tumors (MPNST) from other spindle cell neoplasms (2014) (40)
- Clonality of multiple meningiomas (1997) (40)
- Prognostic stratification of gliomatosis cerebri by IDH1R132H and INA expression (2011) (39)
- Fibroblast Activation Protein–Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study (2021) (38)
- Tryptophan‐2,3‐dioxygenase is regulated by prostaglandin E2 in malignant glioma via a positive signaling loop involving prostaglandin E receptor‐4 (2016) (38)
- Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment (2013) (38)
- Diffuse glioneuronal tumour with oligodendroglioma‐like features and nuclear clusters (DGONC) – a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14 (2019) (33)
- Whole exome sequencing reveals that the majority of schwannomatosis cases remain unexplained after excluding SMARCB1 and LZTR1 germline variants (2014) (32)
- Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model (2010) (31)
- Papillary Tumor of the Pineal Region: A Distinct Molecular Entity (2016) (31)
- Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA (2019) (31)
- Comparative integrated molecular analysis of intraocular medulloepitheliomas and central nervous system embryonal tumors with multilayered rosettes confirms that they are distinct nosologic entities (2015) (30)
- Evidence for Subarachnoid Spread in the Development of Multiple Meningiomas (1995) (29)
- Expression of PACAP and glutamate transporter proteins in satellite oligodendrocytes of the human CNS (2007) (29)
- Pan-Mutant-IDH1 Inhibitor Bay-1436032 Is Highly Effective Against Human IDH1 Mutant Acute Myeloid Leukemia In Vivo (2016) (28)
- Radiotherapy plus concomitant temozolomide in primary gliosarcoma (2016) (28)
- Analysis of TP53 and PTEN in gliomatosis cerebri (2003) (28)
- Accumulation of genomic aberrations during clinical progression of medulloblastoma (2008) (27)
- Amplification and overexpression of CMET is a common event in brain metastases of non‐small cell lung cancer (2014) (26)
- Next Generation Sequencing and Pediatric Brain Tumors: Detection of Cancer Predisposition Syndromes in Patients and Their Families (2017) (26)
- DNA-methylation profiling discloses significant advantages over NanoString method for molecular classification of medulloblastoma (2017) (25)
- Clonal Analysis in Glioblastoma with Epithelial Differentiation (2001) (24)
- Cellular localization of pituitary adenylate cyclase-activating peptide (PACAP) following traumatic brain injury in humans (2007) (24)
- Pretreatment d-2-hydroxyglutarate serum levels negatively impact on outcome in IDH1-mutated acute myeloid leukemia (2016) (24)
- Rare mutations of the DMBT1 gene in human astrocytic gliomas (2002) (23)
- Meningiomas induced by low-dose radiation carry structural variants of NF2 and a distinct mutational signature (2017) (23)
- Differential nuclear ATRX expression in sarcomas (2016) (22)
- Identification of T cell target antigens in glioblastoma stem-like cells using an integrated proteomics-based approach in patient specimens (2017) (21)
- Pilocytic astrocytoma presenting as primary diffuse leptomeningeal gliomatosis: report of a unique case and review of the literature (2005) (21)
- Abstracts for the committee on the genetic constitution of chromosome 1 (1991) (21)
- Prognostic factors and long-term survival in surgically treated brain metastases from non-small cell lung cancer (2016) (21)
- ATIM-33. NOA-16: A FIRST-IN-MAN MULTICENTER PHASE I CLINICAL TRIAL OF THE GERMAN NEUROONCOLOGY WORKING GROUP EVALUATING A MUTATION-SPECIFIC PEPTIDE VACCINE TARGETING IDH1R132H IN PATIENTS WITH NEWLY DIAGNOSED MALIGNANT ASTROCYTOMAS (2018) (20)
- Clonal Origin of Recurrent Meningiomas (1999) (19)
- GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma (2020) (19)
- Do host factors determine long-term survival in glioblastoma? A genome/transcriptome profiling study by the German Glioma Network. (2014) (19)
- HDAC 5 and HDAC 9 in Medulloblastoma : Novel Markers for Risk Stratification and Role in Tumor Cell Growth (2010) (18)
- NDRG1 prognosticates the natural course of disease in WHO grade II glioma (2014) (18)
- Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death (2007) (17)
- Rint1 inactivation triggers genomic instability, ER stress and autophagy inhibition in the brain (2015) (17)
- Molecular characterization of medulloblastomas with extensive nodularity (MBEN) (2018) (15)
- Corrigendum: Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma (2012) (15)
- Proteomics in Pathology (2018) (15)
- Blood BRAFV 600 E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis (2012) (15)
- A new approach to the molecular basis of neoplastic transformation in the brain (1992) (13)
- Grading of diffuse astrocytic gliomas: Broders, Kernohan, Zülch, the WHO… and Shakespeare (2017) (13)
- Metronomic chemotherapy with daily low-dose temozolomide and celecoxib in elderly patients with newly diagnosed glioblastoma multiforme: a retrospective analysis (2015) (13)
- GAPVAC-101: First-in-human trial of a highly personalized peptide vaccination approach for patients with newly diagnosed glioblastoma. (2018) (12)
- Comparison of automated silver enhanced in situ hybridization and fluorescence in situ hybridization for evaluation of epidermal growth factor receptor status in human glioblastomas (2009) (12)
- FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomas (2019) (11)
- The mTOR target NDRG 1 confers MGMT-dependent resistance to alkylating chemotherapy (2017) (11)
- Mutation analysis of DKK1 and in vivo evidence of predominant p53-independent DKK1 function in gliomas (2005) (11)
- Gain of 12p encompassing CCND2 is associated with gemistocytic histology in IDH mutant astrocytomas (2016) (11)
- Post-operative cardiovascular complications and time to recurrence in meningioma patients treated with versus without pre-operative embolization: a retrospective cohort study of 741 patients (2018) (11)
- Phase I/II study of cetuximab plus temozolomide as radiochemotherapy for primary glioblastoma (GERT)—Eudract number 2005–003911–63; NCT00311857 (2008) (11)
- Transcriptional profiling of medulloblastoma with extensive nodularity (MBEN) reveals two clinically relevant tumor subsets with VSNL1 as potent prognostic marker (2019) (10)
- Histone epiproteomic profiling distinguishes oligodendroglioma, IDH-mutant and 1p/19q co-deleted from IDH-mutant astrocytoma and reveals less tri-methylation of H3K27 in oligodendrogliomas (2019) (10)
- The pediatric precision oncology study INFORM: Clinical outcome and benefit for molecular subgroups. (2020) (10)
- Expression of glucose transporter 1 is associated with loss of heterozygosity of chromosome 1p in oligodendroglial tumors WHO grade II (2008) (10)
- MAP kinase activity supported by BRAFV600E mutation rather than gene amplification is associated with ETV1 expression in melanoma brain metastases (2014) (9)
- GRHL 1 Acts as Tumor Suppressor in Neuroblastoma and Is Negatively Regulated by MYCN and HDAC 3 (2013) (9)
- Frame-based stereotactic biopsies using an intraoperative MR-scanner are as safe and effective as conventional stereotactic procedures (2018) (9)
- Abstracts for the committee on comparative gene mapping (1991) (9)
- Radiotherapy in relation to temozolomide: Subgroup analysis of molecular markers of the randomized phase III study by the EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033) in patients with a high risk low-grade glioma. (2015) (9)
- Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and CDK6 amplifications and share a common DNA methylation signature (2021) (9)
- Farewell to oligoastrocytoma: response to letters (2014) (8)
- Molecular genetic classification of astro cytic and oligodendroglial tumors (1997) (7)
- Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma (2019) (7)
- Effect of an algorithm and patient information on serum phosphorus levels. (1984) (7)
- Abstract 3687: An integrative genomics approach identifies distinct molecular and epigenetic subgroups of pediatric glioblastoma (2012) (7)
- Identification of a novel selective inhibitor of mutant isocitrate dehydrogenase 1 at allosteric site by docking-based virtual screening (2016) (7)
- The transcription factor Ets-1 is expressed in human amniochorionic membranes and is up-regulated in term and preterm premature rupture of membranes (2005) (7)
- SCLEROSING EPITHELIOID MESENCHYMAL NEOPLASM OF THE PANCREAS A PROPOSED NEW ENTITY (2019) (7)
- Characterization of the Human Rad 51 Genomic Locus and Examination of Tumors with 15 q 14 – 15 Loss of Heterozygosity ( LOH ) 1 (1999) (6)
- Mutation and deletion analysis of GFRα-1, encoding the co-receptor for the GDNF/RET complex, in human brain tumours (1999) (6)
- A role for b-melanocyte-stimulating hormone in human bodyweight regulation (6)
- EGFR gene amplification and variant III (EGFRvIII) mutation in primary and recurrent glioblastoma. (2016) (6)
- Desmoplastic/nodular medulloblastomas (DNMB) and medulloblastomas with extensive nodularity (MBEN) disclose similar epigenetic signatures but different transcriptional profiles (2019) (6)
- p53 Accumulation Promotes Dephosphorylation and Proteolytic Cleavage of Retinoblastoma Protein in Human Malignant Glioma Cells (1997) (6)
- Abstracts for the committee on the genetic constitution of the X chromosome (Part 3 of 3) (1991) (5)
- Impact of post-surgical freezing delay on brain tumor metabolomics (2019) (5)
- Umbrella protocol for phase I/IIa trials of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed glioblastoma without MGMT promoter methylation Neuro Master Match (N²M²). (2016) (5)
- Abstracts for the committee on the genetic constitution of chromosome 17 (1991) (5)
- RESULTS OF THE INTERNATIONAL INTERLABORATORY COMPARISON OF MGMT PROMOTER METHYLATION ANALYSIS INVOLVING TWENTY-THREE ACADEMIC CENTERS IN GERMANY, AUSTRIA AND THE NETHERLANDS (2014) (4)
- Abstracts for the committee on the genetic constitution of chromosome 2 (1991) (4)
- VXM01 phase I study in patients with progressive glioblastoma: Final results. (2018) (4)
- [On the prognosis of hip fractures. Assessment of mortality after hip fractures by analyzing overlapping segments of longitudinal data]. (2005) (4)
- Guidelines on the Management of Low-grade Gliomas: EANO Task Force Report (2012) (4)
- Osteosarcoma: novel prognostic biomarkers using circulating and cell-free tumour DNA (2021) (4)
- MOLECULAR GENETIC ALTERATIONS IN PEDIATRIC BRAIN STEM GLIOMAS (1993) (4)
- 45‐ YEAR‐OLD MALE WITH SYMPTOMATIC MASS IN THE FRONTAL LOBE (2006) (4)
- Anendogenous tumour-promoting ligand of the human aryl hydrocarbon receptor (2011) (4)
- [On general practitioners' care of patients with asthma]. (2012) (4)
- Utilization of a MAB for BRAFV 600 E detection in papillary thyroid carcinoma (2012) (4)
- Mapping pediatric brain tumors to their origins in the developing cerebellum (2021) (4)
- NEXT-GENERATION NEUROPATHOLOGY - IMPROVING DIAGNOSTIC ACCURACY FOR BRAIN TUMORS USING DNA METHYLATION ARRAY-BASED MOLECULAR PROFILING (2014) (4)
- Abstracts for the committee on the genetic constitution of chromosome 6 (1991) (4)
- IMPS-14PROGNOSTIC ROLE OF REGULATORY T-CELLS IN PRIMARY AND RECURRENT MENINGIOMA. (2015) (3)
- Abstracts for the committee on the genetic constitution of chromosome 15 (1991) (3)
- Abstracts for the committee on chromosomal changes in neoplasia (1991) (3)
- Abstracts for the committee on the genetic constitution of chromosome 12 (1991) (3)
- Determining the glioma CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide methylation data in the biomarker cohort of the NOA-04 trial. (2014) (3)
- DNA methylation-based age acceleration observed in IDH wild-type glioblastoma is associated with better outcome—including in elderly patients (2022) (3)
- Biomarkers for malignant peripheral nerve sheath tumours. (2008) (3)
- Erbitux® (Cetuximab) Plus Temozolomide as Radiochemotherapy for Primary Glioblastoma (GERT): Interim Results of a Phase I/II Study (2008) (3)
- TP53 mutations and drug sensitivity in acute myeloid leukaemia cells with acquired MDM2 inhibitor resistance (2018) (3)
- IDH1 mutant glioma initiating cells are predisposed to apoptosis under endoplasmic reticulum (ER) stress (2018) (2)
- Abstract LB-80: ATRX loss refines the classification of anaplastic glioma and is a favorable prognostic marker. (2013) (2)
- P01.013 Long-term analyses of the NOA-08 randomized phase III trial of temozolomide versus radiotherapy for elderly patients with malignant astrocytomas (2018) (2)
- Reply to J.C. Lindsey et al (2011) (2)
- An endogenous ligand of the human aryl hydrocarbon receptor promotes tumor formation (2017) (2)
- VXM01 phase I study in patients with resectable progression of a glioblastoma. (2017) (2)
- Final results of APG101_CD_002: APG101 plus reirradiation versus reirradiation in the treatment of patients with progressive glioblastoma. (2014) (2)
- CELL BIOLOGY AND SIGNALING (2010) (2)
- Molecular progression of SHH-activated medulloblastomas (2019) (2)
- Efficacy of re-irradiation with carbon ions (RiCi) in patients with recurrent high-grade glioma (rHGG) compared to the standard re-irradiation with photons (RiP): The reference multicenter cohort of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). (2019) (2)
- BRAF V600E Mutations in Multiple Myeloma: Clinical and Therapeutic Implications (2012) (2)
- GENE-08. THE MNP 2.0 STUDY: PROSPECTIVE INTEGRATION OF DNA METHYLATION PROFILING IN CNS TUMOR DIAGNOSTICS (2019) (2)
- Identification of New Inhibitors of Mutant Isocitrate Dehydrogenase 2 through Molecular Similarity-based Virtual Screening (2019) (2)
- Cerebral metastases of a dermatofibrosarcoma protuberans (2019) (2)
- Radiochemotherapy with daily concomitant and adjuvant one week on/one week off temozolomide plus indomethacin in newly diagnosed glioblastoma: A phase II trial (2008) (2)
- Impact of the New WHO Classification on Decision-making for Radiation Therapy in Patients with Atypical and Anaplastic Meningiomas (2009) (2)
- Differential patterns of molecular genetic alterations define subsets among glioblastomas and oligoastrocytomas (1998) (2)
- Abstracts for the committee on the genetic constitution of chromosome 16 (1991) (2)
- Abstracts for the committee on the genetic constitution of chromosome 22 (1991) (2)
- PDCT-05. MOLECULAR DIAGNOSTICS REVEAL 60% HIGHER SURVIVAL FOR MOLECULARLY-VERIFIED VERSUS HISTOPATHOLOGICALLY-DIAGNOSED PEDIATRIC SUPRATENTORIAL CENTRAL NERVOUS SYSTEM EMBRYONAL TUMORS AND PINEOBLASTOMAS; A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP ACNS0332 TRIAL (2017) (2)
- Solides kraniopharyngeom im III. Ventrikel - Differential-diagnostische aspekte (1998) (2)
- PROGNOSTIC AND PREDICTIVE BIOMARKER-BASED SUBGROUPS IN THE NOA-04 TRIAL (2014) (2)
- Clinical Epidermal Growth Factor Receptor Variant III ( EGFRvIII ) Positivity in EGFR-Ampli fi ed Glioblastomas : Prognostic Role and Comparison between Primary and Recurrent Tumors (2017) (2)
- Abstracts for the committee on the genetic constitution of chromosome 11 (1991) (2)
- Abstract 2645: BAY 1436032: A highly selective, potent and orally available inhibitor of mutant forms of IDH1 (2016) (2)
- Validation of Prognostic Significance of IDH1 and MGMT in Patients with Glioblastoma: One Step Forward, and One Step Back? (2010) (2)
- SPONTANEOUS IMMUNE RESPONSES IN GBM PATIENTS AFTER COMPLETE TUMOR RESECTION ARE ASSOCIATED WITH AN IMPROVED SURVIVAL (2014) (2)
- MBCL-21. EARLY CHILDHOOD MEDULLOBLASTOMA: SUBGROUP-SPECIFIC SURVIVAL IN PATIENTS TREATED WITH SYSTEMIC CHEMOTHERAPY AND INTRAVENTRICULAR MTX TO AVOID CRANIOSPINAL RADIOTHERAPY (2018) (1)
- P04.22OLIGOASTROCYTOMA DOES NOT EXIST: A MOLECULAR GENETIC REAPPRAISAL ON SINGLE-CELL LEVEL (2014) (1)
- WHO Guidelines for Diagnosis of Glial Tumours : What Is Old and What Is New ? (2011) (1)
- MCP-1 as an Effector of IL-31 Signaling in Familial Primary Cutaneous Amyloidosis (2013) (1)
- OMICS AND PROGNSTIC MARKERS (2013) (1)
- FAM131B-BRAF Fusion Gene Resulting From 7q34 Deletion Leads to MAPK Pathway Activation in Pilocytic Astrocytoma (2011) (1)
- Long-term survival in primary glioblastoma revisited: The contribution of isocitrate dehydrogenase mutations. (2013) (1)
- KS01.3.A Tumoral MHC class II expression in gliomas drives T cell exhaustion (2021) (1)
- NIMG-02. NON-INVASIVE DETECTION OF IDH MUTANT 1p19q NON-CODELETED GLIOMAS USING THE T2-FLAIR MISMATCH SIGN (2019) (1)
- P01.133 Preoperative predictors of malignancy in non-enhancing glioma in the era of molecular classification (2018) (1)
- GENE-12. ANAPLASTIC NEUROEPITHELIAL TUMOR WITH CONDENSED NUCLEI (ANTCON): A NOVEL BRAIN TUMOR ENTITY WITH RECURRENT NTRK FUSION (2019) (1)
- OS07.1 Molecular differences in IDH wild type glioblastoma according to MGMT promoter methylation status. (2017) (1)
- Clinical and molecular features associated with long-term survival of elderly patients with glioblastoma. (2017) (1)
- Abstracts for the committee on the genetic constitution of chromosome 7 (2004) (1)
- Abstract 1424: KCNJ2 comprises a marker of poor prognosis and a therapeutic target in non-WNT/non-SHH medulloblastoma (2012) (1)
- Abstract 3240: The Wnt secretion factor Evi/Wls/Gpr177 promotes glioma tumorigenesis (2012) (1)
- Abstracts for the committee on the genetic constitution of chromosome 13 (1991) (1)
- Molecular classification of diffuse cerebral gliomas using genome- and transcriptome-wide profiling. (2015) (1)
- Abstracts for the committee on the genetic constitution of chromosome 10 (1991) (1)
- ACTR-05. THE RANDOMIZED PHASE II ARTE TRIAL: BEVACIZUMAB PLUS HYPOFRACTIONATED RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (2017) (1)
- The INFORM personalized medicine study for high-risk pediatric cancer patients. (2017) (1)
- DNA methylation array-based molecular profiling for brain tumor classification (2015) (1)
- HG-68COMBINED ALTERATIONS IN MAPK PATHWAY GENES, CDKN2A/B AND ATRX CHARACTERIZE ANAPLASTIC PILOCYTIC ASTROCYTOMA (2016) (1)
- fundiInhibition of CD95/CD95L Signaling with APG101 Prevents Invasion and Enhances Radiation Therapy for Glioblastoma (2018) (1)
- OS6.1 Molecular characterization of astroblastoma (2016) (1)
- OS11.5.A PATZ1 fusions define a novel molecularly distinct CNS tumor entity with a broad histological spectrum (2021) (1)
- Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial ependymoma (2021) (1)
- Abstracts for the committee on the genetic constitution of chromosome 4 (1991) (1)
- Erratum to: Gliomatosis cerebri: no evidence for a separate brain tumor entity (2016) (1)
- GRHL1 inhibits tumorigenicity and is a prognostic marker in neuroblastoma (2013) (1)
- Machine Learning Improves Diagnosis of CNS Cancers. (2018) (1)
- MNGI-13. A DNA METHYLATION-BASED CLASSIFIER FOR ASSESSMENT OF RISK OF RECURRENCE IN MENINGIOMA (2018) (1)
- Abstract 2654: GAPVAC-101 phase I trial: First data of an innovative actively personalized peptide vaccination trial in patients with newly diagnosed glioblastoma (2016) (1)
- OS2.1 Immune responses to a mutation-specific peptide vaccine targeting IDH1R132H in patients with IDH1R132H-mutated gliomas. (2016) (1)
- Abstracts for the committee on the genetic constitution of the Y chromosome (1991) (1)
- TB-11MOLECULAR NEUROPATHOLOGY 2.0 - INCREASING DIAGNOSTIC ACCURACY IN PEDIATRIC NEUROONCOLOGY (2016) (1)
- Abstracts for the committee on the genetic constitution of chromosome 9 (1991) (1)
- Abstract 1906: PFKFB4, much more than just a glycolytic gene (2018) (0)
- Abstracts for the committee on the genetic constitution of chromosome 19 (1991) (0)
- Identification of the Prognostic Signatures for Isocitrate Dehydrogenase Mutant Glioma (2022) (0)
- SOCIETY NEWS (2006) (0)
- GE-30OLIGOASTROCYTOMA DOES NOT EXIST: IN-SITU MOLECULAR GENETICS FAVORS CLASSIFICATION AS EITHER OLIGODENDROGLIOMA OR ASTROCYTOMA (2014) (0)
- P02.03 Multiple sclerosis and gliomas - a coincidence? (2016) (0)
- Histone deacetylases 5 and 9 are novel markers for medulloblastoma risk stratification and potential drug targets for therapy (2009) (0)
- P01.031 VXM01 phase I study in patients with progressive glioblastoma - final results (2018) (0)
- Abstract 3093: Unravelling the biology of aggressive and therapy-resistant embryonal tumors with multilayered rosettes (ETMR) (2014) (0)
- Em-24. Telomerase Inhibition Induces Growth Arrest in Paediatric Ependymoma (2012) (0)
- OS3.6 Development and validation of a DNA methylome-based predictor of meningioma recurrence and meningioma recurrence score (2018) (0)
- Abstract 2182: Preclincial in vitro and in vivo combination therapies for mutant IDH1R132 tumors with BAY 1436032 (2019) (0)
- Abstract B71: Molecular heterogeneity and novel oncogenic fusions in RELA- and YAP1-negative supratentorial ependymoma (2020) (0)
- Tandem duplications of 7q34 and 3q25 in pilocytic astrocytoma result in RAF fusion genes (2010) (0)
- LGG-11. REGULATION OF ONCOGENE-INDUCED SENESCENCE IN PILOCYTIC ASTROCYTOMA (2018) (0)
- Abstract B075: Modeling response and resistance to immune checkpoint blockade in syngeneic mouse glioma (2019) (0)
- Suppression of invasion-driving RGS 4 by radiation-enhanced mTOR inhibition optimizes antiangiogenesis (2017) (0)
- LGG-13. PAPILLARY GLIONEURONAL TUMOR (PGNT) EXHIBITS A CHARACTERISTIC METHYLATION PROFILE AND MANDATORY FUSIONS INVOLVING PRKCA (2019) (0)
- Nestin protein expression is an independent prognostic marker in ependymoma and discriminates WHO II ependymoma with poor outcome (2012) (0)
- P06.06 A mutation-specific vaccine for Histone-3 K27M-mutated gliomas. (2017) (0)
- P04.79 Cytotoxic T cells and their activation status are independent prognostic markers in meningiomas (2018) (0)
- MPTH-23. LONG-TERM SURVIVAL WITH GLIOBLASTOMA IN THE ELDERLY (2016) (0)
- INFORMING TREATMENT DECISIONS IN RELAPSED PEDIATRIC MALIGNANCIES USING NEXT-GENERATION DIAGNOSTICS (2014) (0)
- Abstract A020: Immunomonitoring for actively personalized peptide vaccines (APVACs) during immunotherapeutic treatment of glioblastoma (2019) (0)
- CSIG-27. DIFFERENTIAL ELEVATION OF TERT ACTIVITY AND SENSITIVITY TO TEMOZOLOMIDE BY TYPE OF TERT MUTATION IN MGMT PROMOTER-METHYLATED GLIOBLASTOMA (2018) (0)
- High-dose radiation therapy using photons and carbon ion radiotherapy in patients with atypical and anaplastic meningiomas: Relevance of neuropathologic classification and therapeutic impact of a boost using of carbon ion radiotherapy. (2010) (0)
- Abstract 1432: The heterogeneous genomic landscape of posterior fossa ependymoma (2012) (0)
- Anaplastic pilocytic astrocytoma-an IDH-wildtype diffuse glioma characterized by a distinct DNA methylation profile and combined alterations in MAPK pathway genes, CDKN2A/B and ATRX (2017) (0)
- Fibroblast Activation Protein specific PET: A novel imaging method for IDH-wildtype Glioblastomas and IDH-mutant Gliomas (2019) (0)
- MNGI-28. CORRELATION OF METHYLATION CLASS AND GENETIC ALTERATIONS WITH PROGRESSION FREE SURVIVAL IN MENINGIOMA (2018) (0)
- MYCN transcriptionally represses CD9 to trigger an invasion-metastasis cascade in neuroblastoma (2015) (0)
- Targeting class I histone deacetylases in high risk medulloblastoma – analysis of molecular mechanisms and translational implications (2014) (0)
- LG-27DKFZ-BT66 - A NOVEL PILOCYTIC ASTROCYTOMA MODEL FOR PRECLINICAL DRUG TESTING (2016) (0)
- SOCIETY NEWS (2005) (0)
- Abstract 1178: Identification of a novelBRAFfusion partner in pilocytic astrocytoma (2010) (0)
- IMMU-49. CYTOTOXIC T CELLS AND THEIR ACTIVATION STATUS ARE INDEPENDENT PROGNOSTIC MARKERS IN MENINGIOMAS (2018) (0)
- PO-0993: Genetic profiles of glioblastoma in proximity to the subventricular zone receiving chemoradiation (2016) (0)
- Cancer esearch apeutics , Targets , and Chemical Biology e of LIM and SH 3 Protein 1 ( LASP 1 ) in the Metastatic R emination of Medulloblastoma (2010) (0)
- Abstract LB-114: The INFORM personalized medicine study for high-risk pediatric cancer patients (2015) (0)
- OS2.4 Expression and relevance of tumoral and stromal MHC class II in gliomas (2016) (0)
- OS2.3 A mutation-specific vaccination approach for Histon H3.3 K27M-mutated gliomas (2016) (0)
- Abstract 4699: Oncogenic fusion genes resulting from 7q34 deletions constitute a novel mechanism of MAPK pathway activation in pilocytic astrocytoma (2011) (0)
- ATIM-20. GAPVAC-101 TRIAL OF A HIGHLY PERSONALIZED PEPTIDE VACCINATION FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (2018) (0)
- Advances in Brief p53 Mutations Are Associated with 17p Allelic Loss in Grade II and Grade III Astrocytoma1 (2006) (0)
- IMMU-54. THE ONCOMETABOLITE R-2-HYDROXYGLUTARATE SUPPRESSES THE INNATE IMMUNE MICROENVIRONMENT OF IDH1-MUTATED GLIOMAS VIA ARYL HYDROCARBON RECEPTOR SIGNALING (2018) (0)
- Abstracts dscribing resources, technological and other developments (1991) (0)
- A Vaccine Targeting Mutant IDH1 Induces Antitumor Immunity (S22.001) (2014) (0)
- FISH-, expression- and methylation analyses of p16 correlated with response to TMZ-chemotherapy in patients with glioblastoma (2007) (0)
- Recurrent MET fusion genes represent a druggable target in paediatric glioblastoma 1 2 (2016) (0)
- Subject Index Vol. 7, 1997 (1997) (0)
- 360O Telomerase reverse transcriptase (TERT) promoter mutation and O6-methylguanine DNA methyltransferase (MGMT) promoter methylation-mediated sensitivity to temozolomide in IDH-wildtype glioblastoma: Is there a link? (2020) (0)
- Abstract 31: Subgroup-specific molecular alterations may explain the tremendous clinical heterogeneity of intracranial ependymoma (2010) (0)
- SOCIETY NEWS (2005) (0)
- Abstract 4277: Development and validation of a novel IDH1-mutant astrocyte cell line as a model for high-grade gliomas (2016) (0)
- The Pediatric Brain Tumor Preclinical Testing Program: update and perspectives (2013) (0)
- PATH-24. MOLECULAR SUBGROUPS OF ADULT EPENDYMAL TUMORS: AN ANALYSIS OF THE GERMAN GLIOMA NETWORK (2017) (0)
- Targeting differentially expressed histone deacetylases in Medulloblastoma – novel approach for treatment of high risk patients (2013) (0)
- 138 The MDM2 Inhibitor Nutlin-3 But Not the p53 Activator RITA Induces Loss-of-function p53 Mutations (2012) (0)
- Abstracts for the committee on the genetic constitution of chromosome 14 (1991) (0)
- PDTM-47. CHARACTERIZATION OF THE SENESCENCE-ASSOCIATED SECRETORY PHENOTYPE IN PILOCYTIC ASTROCYTOMA AND ITS ROLE IN ONCOGENE-INDUCED SENESCENCE (2017) (0)
- P09.18 Location-dependent prognostic factors and recurrence patterns in IDH wildtype glioblastoma. (2017) (0)
- Abstracts for the committee on the genetic constitution of the X chromosome (Part 2 of 3) (2004) (0)
- Promoter hypermethylation and aberrant expression of EMP3at 19q13.3 in oligodendrogliomas and astrocytomas (2007) (0)
- INTEGRATED SYSTEMS AND TECHNOLOGIES 3206 Application of Raman Spectroscopy to Identify Microcalcifications and Underlying Breast Lesions at Stereotactic Core Needle Biopsy (2013) (0)
- OS12.7.A Characterization of intra-tumoral heterogeneity and differential immune activation during malignant progression of meningiomas on single cell level (2021) (0)
- O6.09PROSTAGLANDIN E RECEPTOR-4 ACTIVATION REGULATES TRYPTOPHAN METABOLISM IN HUMAN MALIGNANT GLIOMAS (2014) (0)
- TBIO-10. PEDIATRIC TARGETED THERAPY 2.0: DEVELOPMENT OF PERSONALIZED PEDIATRIC ONCOLOGY (2018) (0)
- Abstract 11: Advancing methylation profiling in neuropathology: Diagnosis and clinical management (2016) (0)
- BIOM-59. TERT PROMOTER MUTATION AND MGMT PROMOTER METHYLATION-MEDIATED SENSITIVITY TO TEMOZOLOMIDE IN IDH-WILDTYPE GLIOBLASTOMA: IS THERE A LINK? (2020) (0)
- Prognostic value of histopathologic grading of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheet tumour: need for a novel grading system? (2006) (0)
- IMST-34. IMMUNOLOGICAL CHANGES DURING TUMOR PROGRESSION FROM PRIMARY TO RECURRENT GLIOBLASTOMA (2016) (0)
- GENE-06. DISTINCT MOLECULAR SUBGROUPS OF TUMORS OF THE PINEAL REGION CORRELATE WITH CLINICAL PARAMETERS AND GENETIC ALTERATIONS (2019) (0)
- Advances in Brief p 53 Mutations Are Associated with 17 p Allelic Loss in Grade II and Grade III Astrocytoma 1 (2006) (0)
- Characterization of oncogene-induced senescence and the role of the senescence-associated secretory phenotype in pilocytic astrocytoma (2017) (0)
- MUTATIONS IN THE IDH GENE (R13211) ARE NOT SUFFICIENT FOR EXPERIMENTAL GLIOMAGENESIS (2017) (0)
- Opinion & Special Article: Glioma Classi fi cation How to Interpret Molecular Markers in a Di ff use Glioma Pathology Report (0)
- In situ proximity ligation assay to evaluate presentation of a mutated CD4 epitope in human glioma tissue (2014) (0)
- Utilization of a MAB for BRAF detection in papillary thyroid carcinoma (2012) (0)
- Metronomic chemotherapy with daily low-dose temozolomide and celecoxib in elderly patients with newly diagnosed glioblastoma multiforme. (2015) (0)
- Abstract 3646: (Epi-)genomic homogeneity in radiation-induced glioblastoma with recurrentPDGFRAamplification and loss ofCDKN2A/Bfollowing primary acute lymphatic leukemia and medulloblastoma (2019) (0)
- INFORM: personalized pediatric oncology enters the clinic (2014) (0)
- Expression of DNA methyl transferases and promoter methylation of tumor suppressor genes in astrocytomas (2008) (0)
- Subject Index Vol. 58, 1991 (1991) (0)
- Metronomic Chemotherapy With Daily Low Dose Temozolomide and Celecoxib in Elderly Patients With Newly Diagnosed Glioblastoma Multiforme: A Retrospective Analysis (2015) (0)
- NIMG-09. NONINVASIVE PERFUSION IMAGING BIOMARKER OF MALIGNANT GENOTYPE IN ISOCITRATE DEHYDROGENASE MUTANT GLIOMAS (2019) (0)
- SP-0656: Two years since the release of new WHO classification of CNS tumors: what has come up new and how to implement this? (2018) (0)
- Abstracts for the committee on the mitochondrial genome (1991) (0)
- Differential elevation of TERT activity and sensitivity to temozolomide by type of TERT mutation in MGMT promoter-methylated glioblastoma. (2018) (0)
- Biological and clinical heterogeneity of MYCN-amplified (2012) (0)
- MOLECULAR GENETIC DETERMINANTS OF LONG-TERM SURVIVAL WITH GLIOBLASTOMA (2014) (0)
- 2205 Preoperative chemoptherapy (CT) and twice daily radio-chemotherapy (HA RT/CT) versus preoperative chemotherapy alone in stage III non small cell lung cancer: Analysis of toxicity of a randomized trial (1999) (0)
- Abstracts for the committee on clinical disorders and chromosomal deletion syndromes (1991) (0)
- Umbrella protocol for phase I/IIa trials of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed glioblastoma without MGMT promoter methylation Neuro Master Match (N{superscript 2}M{superscript 2}). (2016) (0)
- Chelation of iron enhances invasion of glioblastoma cells (2007) (0)
- Cancer Therapy : Clinical A Phase II , Randomized , Study of Weekly APG 101 þ Reirradiation versus Reirradiation in Progressive Glioblastoma (2014) (0)
- Retraction: Withdrawal: Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma (Molecular & cellular proteomics : MCP (2018) 17 11 (2132-2145)) (2019) (0)
- MNGI-14. LOSS OF HISTONE H3K27me3 IDENTIFIES A SUBSET OF MENINGIOMAS WITH INCREASED RISK OF RECURRENCE (2018) (0)
- Dysregulated expression of histone deacetylases in medulloblastoma - potential targets for selective inhibitor treatment (2013) (0)
- SOCIETY NEWS (2004) (0)
- SURG-16PROGNOSTIC VALUE OF THE EXTENT OF RESECTION AND IDH1 MUTATION STATUS IN WHO GRADE II ASTROCYTOMAS (2015) (0)
- Identification of Two Molecular and Clinical Distinct Entities of Posterior Fossa Ependymoma (2011) (0)
- Molecular Characterization of Radiation-induced Glioblastoma (2018) (0)
- Towards a molecular algorithm predicting glioma treatment response and resistance: A biomarker analysis and path to real time profiling in N2M2. (2018) (0)
- P04.62 The oncometabolite R-2-Hydroxyglutarate suppresses the innate immune microenvironment of IDH1-mutated gliomas via aryl hydrocarbon receptor signaling (2018) (0)
- Differential diagnostic impact of DNA methylation profiling on brain tumor classification (2019) (0)
- P08.76 Anti-EGFL7 treatment as an add-on for glioma therapy (2016) (0)
- Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD (2023) (0)
- The Pediatric Brain Tumor Preclinical Testing Program: an update on the current status (2012) (0)
- EG-09EPIGENETIC PROFILING REVEALS A CpG HYPERMETHYLATION PHENOTYPE (CIMP) ASSOCIATED WITH WORSE PROGRESSION-FREE SURVIVAL IN MENINGIOMA. (2014) (0)
- OS6.4 Molecular classification of meningiomas across all histological subtypes and grades (2016) (0)
- Abstracts for the committee on linkage and gene order (1991) (0)
- Abstract IA11: Pediatric precision oncology programs in Germany and Europe (2018) (0)
- Abstracts for the committee on the genetic constitution of chromosome 20 (1991) (0)
- Abstractsfor the informatics committee (1991) (0)
- THE GENETIC HETEROGENEITY OF POSTERIOR FOSSA EPENDYMOMA (2012) (0)
- TBIO-07. ASSESSING THE UTILITY OF DNA METHYLATION PROFILING IN BRAIN TUMOR DIAGNOSTICS—THE PROSPECTIVE MNP2.0 STUDY (2018) (0)
- ACTR-61. LONG-TERM ANALYSES OF THE NOA-08 RANDOMIZED PHASE III TRIAL (2018) (0)
- Abstract 3094: Epigenetic classification of ependymal brain tumors across age groups (2014) (0)
- OP08. MUTATIONS IN THE IDH GENE (R132H) ARE NOT SUFFICIENT FOR EXPERIMENTAL GLIOMAGENESIS (2017) (0)
- 892: Peripheral T cell responses in glioblastoma patients are associated with an improved survival (2014) (0)
- Pediatrics Laboratory Research (2010) (0)
- Histone Deacetylase 8i n NeuroblastomaTumorigenesis (2009) (0)
- Abstracts for the committee on the genetic constitution of chromosome 18 (1991) (0)
- Methylation among members of the PI3K/AKT/mTOR pathway in melanoma brain and extracerebral metastases. (2018) (0)
- Abstract 4736: N-myc downstream regulated gene 1: A novel mediator of hypoxia-driven chemoresistance in glioblastoma (2012) (0)
- Personalized pediatric oncology: Targeted Therapy and clinical feasibility (2013) (0)
- Abstract 5560: PROX1 expression and function in malignant gliomas (2012) (0)
- Brain metastases of gastro-oesophageal cancer (2013) (0)
- Impact of predictive impact of MGMT promoter methylation in malignant astrocytomas depends on the methylation subgroup. (2019) (0)
- GE-07DNA METHYLATION IN MEDULLOBLASTOMA AND MOLECULAR DIAGNOSTICS OF BRAIN TUMORS. (2015) (0)
- Review Article - Oligodendrogliomas: Impact of molecular genetics on treatment (2005) (0)
- Online Database Featuring Author , Key Word and Full-Text Search Guidelines on the Management of Low-grade Gliomas : EANO Task Force Report (2018) (0)
- Index of GDB source ID numbers (1991) (0)
- Abstracts for the comparative subcommittee on human and mouse homologies (1991) (0)
- TB-14THE INFORM PERSONALIZED MEDICINE STUDY - NEW MOLECULAR INSIGHTS INTO RELAPSED PEDIATRIC BRAIN TUMORS (2016) (0)
- THE CHROMOSOME 19q GLIOMA TUMOR SUPPRESSOR GENE: DELETION MAPPING AND CANDIDATE GENES (1995) (0)
- Oncogene-induced senescence and the senescence-associated secretory phenotype in pilocytic astrocytoma (2017) (0)
- Radiogenomic rCBV-imaging visualizes the moleculare signature of IDH-mutant and wildtype gliomas (2016) (0)
- [Asthma, nonspecific bronchial hyperreactivity. Asking knowledgable experts]. (2006) (0)
- P05.51 Prognostic impact of genetic alterations and methylation class in meningioma (2018) (0)
- MNGI-02. PREOPERATIVE EMBOLIZATION OF MENINGIOMA: INFERIOR NEUROLOGICAL OUTCOME, INCREASED RISK OF CARDIOVASCULAR COMPLICATIONS AND SHORTER TIME TO RECURRENCE? (2017) (0)
- Abstract 1889: Next-generation neuropathology - Improving diagnostic accuracy for brain tumors using DNA methylation array-based molecular profiling (2014) (0)
- P09.09 Gain of 12p encompassing CCND2 is associated with gemistocytic histology in IDH mutant astrocytomas (2016) (0)
- CB-058. REGULATION OF CANCER PROMOTING TRYPTOPHAN CATABOLISM IN GLIOBLASTOMA BY THE GLUCOCORTICOID RECEPTOR (2013) (0)
- Abstractsfor the DNA committee (1991) (0)
- ANGI-08RADIOGENOMIC rCBV-IMAGING VISUALIZES THE DISTINCT ANGIOGENESIS TRANSCRIPTOME SIGNATURES OF IDH MUTANT AND WILD-TYPE GLIOMAS. (2015) (0)
- Featuring Author , Key Word and Full-Text Search Guidelines on the Management of Low-grade Gliomas : EANO Task Force Report (2016) (0)
- TRTH-09. PTT2.0: DEVELOPING PERSONALIZED PEDIATRIC ONCOLOGY (2017) (0)
- NIMG-51. RADIOLOGIC PHENOTYPES ARE TREATMENT SPECIFIC AND ASSOCIATED WITH SURVIVAL - EXPLORATORY ANALYSIS OF EORTC 26101 (2017) (0)
- Abstracts for the committee on the genetic constitution of chromosome 5 (1991) (0)
- SOCIETY NEWS (2005) (0)
- The Pediatric Brain Tumor Preclinical Testing Program: evaluation of an individualized molecular treatment approach (2011) (0)
- LGG-20. MOLECULARLY-DEFINED DIFFUSE LEPTOMENINGEAL GLIONEURONAL TUMOR (DLGNT) COMPRISES TWO SUBGROUPS WITH DISTINCT CLINICAL AND GENETIC FEATURES (2018) (0)
- Abstract 138: Solid papillary carcinoma with reverse polarization are driven by IDH2 and PI3K pathway mutations (2016) (0)
- DNA methylation profiles of angiosarcoma subtypes (2019) (0)
- Abstracts for the committee on the genetic constitution of chromosome 8 (1991) (0)
- Paul Kleihues (1936–2022), neuropathology innovator and entrepreneur (2022) (0)
- A Model for the Molecular Pathogenesis of Astrocytic Gliomas (1996) (0)
- Abstracts for the committee on the genetic constitution of chromosome 21 (1991) (0)
- OS2.2 Highly personalized peptide vaccination for patients with newly diagnosed glioblastoma: the GAPVAC trial (2018) (0)
- Oncogene Complementation in Fetal Brain Transplants1 (2006) (0)
- Abstract 3453: Induction of differentiation in high-risk ependymoma stem-like cells by treatment with the HDAC inhibitor Vorinostat (2011) (0)
- Mutant IDH1R132H bears a mutation-specific CD4 T cell epitope suitable for vaccination of human CNS tumors (2014) (0)
- P04.52 Spontaneous intratumoral T cell responses against glioblastoma-associated antigens (2018) (0)
- IMMU-41. HIGH-THROUGHPUT RETRIEVAL OF THERAPEUTIC T CELL RECEPTORS FROM GLIOMA (2020) (0)
- Abstract PR15: The oncometabolite R-2-Hydroxyglutarate suppresses the innate immune microenvironment of IDH1-mutated gliomas via aryl hydrocarbon receptor signaling (2019) (0)
- Molecular analysis of meningioma increases prognostic power: A methylation-based classification and grading system (2018) (0)
- Gliomas - ReadingSample (2016) (0)
This paper list is powered by the following services: